Skip to main content

Table 1 Agents used in treatment of angioimmunoblastic T-cell lymphoma

From: Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report

Agent [reference] AITL (no.) ORR/CR (%) Median PFS (months)
Romidepsin [15] 27 30/19 4
Pralatrexate [16] 13 8/NR 3.5
Bendamustine [17] 32 NR 3.6
Brentuximab vedotin [18] 13 54/38 2.6
Lenalidomide [19] 7 29/0 3.2
CHOP [20] 33 NR/61 26
  1. Abbreviations: AITL Angioimmunoblastic T-cell lymphoma, CR Complete response, ORR Overall response rate, PFS Progression-free survival